MARATTO

article · CNS & Neurological Disorders - Drug Targets

Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorderin Children: A Randomized Controlled Trial

Abstract

Coenzyme Q10 has an important role as an add-on drug treatment for attention deficit hyperactivity disorder by improving symptoms, particularly hyperactivity, and in minimizing atomoxetine adverse effects.

Research topics

  • Attention Deficit Hyperactivity Disorder
  • Coenzyme Q10 studies and effects
  • Advanced battery technologies research

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.2174/1871527320666211124093345

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.